Literature DB >> 23384494

Role of aneurysm sac embolization during endovascular aneurysm repair in the prevention of type II endoleak-related complications.

Michele Piazza1, Paolo Frigatti, Paolo Scrivere, Stefano Bonvini, Franco Noventa, Joseph J Ricotta, Franco Grego, Michele Antonello.   

Abstract

OBJECTIVE: The goal of this study was to evaluate the role of intraoperative aneurysm sac embolization during endovascular aneurysm repair (EVAR) using a standard dose of coils and fibrin glue in the prevention of type II endoleak (EII).
METHODS: Two groups were compared: 83 patients underwent standard EVAR during the period 2008-2009 (group A) and 79 patients underwent EVAR during the period 2010-2011 (group B). Computed tomography scans were evaluated with Osirix Pro 4.0 software to obtain aneurysm sac volume. EII rates at the first computed tomography scan follow-up, as well as midterm freedom from EII and freedom from related reintervention, were compared. Preoperative number of patent aortic side branches (inferior mesenteric artery, lumbar arteries, accessory renal arteries), sac thrombus, and sac volume were evaluated for their association with EII in the two groups using multiple logistic regressions.
RESULTS: Patient characteristics, Society for Vascular Surgery comorbidity scores (0.85 ± 0.44 vs 0.82 ± 0.46; P = .96), and operative time (185 ± 52 vs 179 ± 49; P = .92) were similar for groups A and B. The first computed tomography scan (≤3 months) revealed a significantly larger number of EIIs in group A than in group B (23% vs 10%; P = .02). Spontaneous EII resolution occurred in 65% of patients in group A and in 79% in group B (P = 1.0), whereas sac volume increased in 25% and 10% (P = .63) of cases, respectively. At 18 months (range, 6 months to 4.4 years), overall mean differences in sac volume shrinkage (27 ± 12 cm(3) vs 25 ± 12 cm(3); P = .19) and freedom from EII (92% vs 96%; P = .33) were similar, whereas freedom from reintervention was significantly lower in group A (93% vs 99%; P = .03) than in group B. Multivariate analysis showed preoperative aneurysm sac volume >125 cm(3) to be the only independent significant predictor of EII (odds ratio, 4.0; 95% confidence interval, 1.5-10.5; P = .005).
CONCLUSIONS: Although further confirmatory studies are needed, sac embolization during EVAR may be a valid approach to preventing EII and its complications during short- and midterm follow-up. More aggressive intraoperative embolization should be considered for patients with a preoperative aneurysm sac volume >125 cm(3).
Copyright © 2013 Society for Vascular Surgery. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23384494     DOI: 10.1016/j.jvs.2012.10.078

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

1.  A simplified method of pre-emptive perigraft aortic sac embolization to prevent type II endoleak using the Excluder endograft.

Authors:  Brendon Reilly; Mariel Rivero; Hasan H Dosluoglu
Journal:  J Vasc Surg Cases Innov Tech       Date:  2019-11-15

2.  Midterm results of periprosthetic coiling embolization in high-risk patients.

Authors:  Xiantao Li; Yanyan Huang; Pingfan Guo
Journal:  J Interv Med       Date:  2019-10-23

3.  Systematic review and network meta-analysis of pre-emptive embolization of the aneurysm sac side branches and aneurysm sac coil embolization to improve the outcomes of endovascular aneurysm repair.

Authors:  Ye Wu; Jianhan Yin; Zhang Hongpeng; Guo Wei
Journal:  Front Cardiovasc Med       Date:  2022-07-22

Review 4.  Type II endoleaks: challenges and solutions.

Authors:  Andrew Brown; Greta K Saggu; Matthew J Bown; Robert D Sayers; David A Sidloff
Journal:  Vasc Health Risk Manag       Date:  2016-03-02

Review 5.  Techniques and future perspectives for the prevention and treatment of endoleaks after endovascular repair of abdominal aortic aneurysms.

Authors:  Gianluigi Orgera; Marcello Andrea Tipaldi; Florindo Laurino; Pierleone Lucatelli; Alberto Rebonato; Ioannis Paraskevopoulos; Michele Rossi; Miltiadis Krokidis
Journal:  Insights Imaging       Date:  2019-09-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.